Lockhart, I A <br/><br/>
Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.  [electronic resource] 

 -  Dementia and geriatric cognitive disorders  2009 
 - 389-403 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1421-9824 
<br/><br/><label>Standard No.: </label>10.1159/000255578  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alzheimer Disease--drug therapy<br/>Cholinesterase Inhibitors--administration & dosage<br/>Donepezil<br/>Evidence-Based Medicine<br/>Galantamine--administration & dosage<br/>Humans<br/>Indans--administration & dosage<br/>Phenylcarbamates--administration & dosage<br/>Piperidines--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Rivastigmine